Stockreport

Summit completes subject enrolment in Phase III NSCLC treatment trial [Yahoo! Finance]

Summit Therapeutics Inc.  (SMMT) 
Last summit therapeutics inc. earnings: 6/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: summitplc.com/investors/investor-centre
PDF trial of ivonescimab, along with platinum-doublet chemotherapy for the treatment of a certain type of non-small cell lung cancer (NSCLC). Patients from North America, [Read more]